Q and A

Question

Is TLD safe for kidneys?

Hi. My question has to do with HIV meds and the kidneys. What are the chances of developing kidney related issues/problems if on HIV medication and what can one do. Am very worried. Am on TLD. Thank you

Answer

Hi, how are you doing?

Have you had your kidneys tested? Do you know your creatinine clearance and eGFR? or know if you have any problems with your kidneys?

In people with healthy kidneys, TLD rarely causes problems with kidneys. You can help prevent this by avoiding certain medications (that your doctor/pharmacist) and making sure you are drinking plenty of water.

If you have known kidney problems, TLD can have a higher risk of damage but with regular monitoring it is still safe to continue with TLD and if problems do occur (which is rare), alternative treatments can be offered.

TLD is a preferred choice of medication due to a limited side effect profile and is generally well tolerated by people.

Josh.

6 comments

  1. Simon Collins

    Hi Emmanuel – thanks for your comment :)

  2. Emmanuel

    Thanks Jose, I have started taking it at night. I forgot to ask this: I was on Effavirenz before moving to TLD not because of any reason but they said the supply is only on TLD. But due to the side effect I have experienced over the years that’s why I am deciding to go back to TLE.

    Hope it is safe? My count is undectected

  3. Simon Collins

    Hi Emmanuel, most people find efavirenz is better before you go to bed. They you can slepp through the side effects that can change your moods. A few people say they can take if during the day, but not many.

  4. Emmanuel

    I have gotten the effavirenz combination, can I take it in the morning or I should revert to night

  5. Josh Peasegood

    Hi Emmanuel, yes it is safe to switch. What type of kidney issues are you having?

  6. Emmanuel

    Thank you for your answer, I am actually having signs of kidney issues and I am on TLD. Is it safe to switch to efavirenz-LT.

Comment

Your email address will not be published. Required fields are marked *